Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy-Reference-Cited by-同舟云学术

Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy

Published:2006-01-27 Issue:5 Volume:27 Page:562-568
ISSN:1522-9645
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Ghio Stefano,Magrini Giulia,Serio Alessandra,Klersy Catherine,Fucilli Alessandro,Ronaszèki Aleksandr,Karpati Pal,Mordenti Giacomo,Capriati Angela,Poole-Wilson Philip A.,Tavazzi Luigi

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/27/5/562/9626135/ehi735.pdf

Reference38 articles.

1. The CIBIS-II investigators and committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trail. Lancet1999;353:9–13.

2. The MERIT-HF study group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trail in congestive heart failure (MERIT-HF). Lancet1999;353:9–13.

3. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A; Roecker Eb, Schultz MK, deMets DL. Carvedilol prospective randomised cumulative survival study group. Effects of carvedilol on survival in severe chronic heart failure. N Engl J Med2001;344:1651–1658.

4. Di Lenarda A, Scherillo M, Maggioni AP, Acquarone N, Ambrosio GB, Annicchiarico M, Bellis P, Bellotti P, De Maria R, Lavecchia R, Lucci D, Mathieu G, Opasich C, Porcu M, Tavazzi L, Cafiero M. Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds—The TEMISTOCLE study. Am Heart J2003;146:e12.

5. Cowie MR, Fox KF, Wood DA, Metcalfe C, Thompson SG, Coats AJ, Poole-Wilson PA, Sutton GC. Hospitalization of patients with heart failure. A population-based study. Eur Heart J2002;23:877–885.

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiological Rationale and Clinical Evidence for Neurohormonal Modulation in Heart Failure with Preserved Ejection Fraction;Cardiac Failure Review;2023-06-05

2. Pharmacotherapies in Heart Failure With Preserved Ejection Fraction;Cardiology in Review;2022-12-27

3. Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin;Heart Failure Reviews;2022-04-29

4. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction;Cochrane Database of Systematic Reviews;2021-05-22

5. Chronic Kidney Disease as a Risk Factor for Heart Failure With Preserved Ejection Fraction: A Focus on Microcirculatory Factors and Therapeutic Targets;Frontiers in Physiology;2019-09-04